Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD
Durvalumab联合化疗治疗一线奥希替尼治疗后疾病进展的EGFR突变晚期非小细胞肺癌患者:ORCHARD
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100937
Cho, Byoung Chul; Nishio, Makoto; Ahn, Myung-Ju; García-Campelo, Rosario; Ponce, Santiago; Baik, Christina; Salgia, Ravi; Kim, Sang-We; Lee, Jong Seok; Yoshida, Tatsuya; Yu, Helena A; Goldberg, Sarah B; Johannes de Langen, Adrianus; Le, Xiuning; Piotrowska, Zofia; Riess, Jonathan W; Tanaka, Kentaro; Ambrose, Helen; Cosaert, Jan; Fraenkel, Paula G; Tang, Kwan Ho; Lehman, Jonathan M; Smith, Paul; Goldman, Jonathan W